If you're interested in becoming a contributor or requesting changes then click here to join the discord
Difference between revisions of "Neuronetics"
Landonodnal (talk | contribs) |
Landonodnal (talk | contribs) |
||
Line 17: | Line 17: | ||
[[:Category:Neurostimulation_Techniques|Neurostimulation Technique(s)]]: TMS | [[:Category:Neurostimulation_Techniques|Neurostimulation Technique(s)]]: TMS | ||
+ | |||
+ | ==Hardware== | ||
+ | *[[NeuroStar_TMS|NeuroStar TMS]] | ||
==Links== | ==Links== | ||
[https://neurostar.com/neuronetics/ Website] | [https://neurostar.com/neuronetics/ Website] |
Revision as of 18:26, 15 January 2023
'Neuronetics is a Malvern, PA based, publicly traded company incorporated in Delaware in April 2003, that develops non-invasive treatments for depression and other chronic psychiatric and neurological disorders based upon neuromodulation technology. Neuronetics became "the first company to get FDA authorization for a transcranial magnetic stimulation (TMS) device to treat major depressive disorder in 2008." They manufacture a transcranial magnetic stimulation device.'
Founded in The United States around 2003, Neuronetics produces noninvasive hardware and end-user software.
Neuronetics makes tools for medical diagnosis and treatment through body/mind state interpretation and/or neurostimulation therapies.
BCI Categories: Open-Loop Afferent
Neurostimulation Technique(s): TMS
Hardware
Links
Website Wikipedia Crunchbase LinkedIn TwitterFacebookInstagram YouTube